Novavax enters late-stage clinical trials for experimental Covid-19 vaccine
Published
U.S. biotech firm Novavax said Thursday it was initiating its final Phase 3 clinical trial for its experimental Covid-19 vaccine. The trial will be carried out in the…
Full Article